Connect with us
In 2022, the laboratory closed the financial year with a turnover of more than €272 million, an increase of 15.7% compared to 2021. In Spain, the...
In short, the watch launched by Durcal acts as a solution for elderly people who live alone and are not considering moving to a residence. In...
Both projects started on April 1st, 2023, and are expected to last approximately two years. The biopharmaceutical company reduced its losses by 56% in the first...
Microviable Therapeutics emerged as a spin-off of Ipla-Csic in 2016, focused on the development of therapeutic technologies and products derived from microbiota. Technological development, together with the...
Marsi Bionics aims to invest the capital raised in the round in financing the company's international expansion, accessing new markets, and in the industrialization of production...
Grifols is a publicly traded Catalan pharmaceutical company. The company's activity is focused on the research, development, manufacturing, and marketing of plasma-derived products (blood products), intravenous...
ALA Diagnostics closed its first round of financing in 2021 for the development of the Em Kit, the first test for the early diagnosis of Multiple...
In 2022, the company's results stood at €15.6 million, which translates into a rise of 47.2% compared to the previous year. However, in the same period,...
Grifols has lost around 70% of its market value since the start of the pandemic. In the eyes of investors, its main burdens are debt, which...
Vitro works mainly with public health, which represents between 80% and 85% of its business, and with large private chains. The biotech company has grown to...